Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion type Assertion NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_head.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion description "[Three DNA-based homologous recombination deficiency (HRD) scores (HRD-loss of heterozygosity score (LOH), HRD-telomeric allelic imbalance score (TAI), and HRD-large-scale state transition score (LST)) have been developed that are highly correlated with defects in BRCA1/2, and are associated with response to platinum therapy in triple negative breast and ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion evidence source_evidence_literature NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion SIO_000772 25475740 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion wasDerivedFrom befree-2016 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.
- NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_assertion wasGeneratedBy ECO_0000203 NP1244891.RATtotH2XvEQILRn4Re4HFLyEjHEuGewysbttkSC_HD5g130_provenance.